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Psychiatry in Times of the Coronavirus Disease 2019
(COVID-19) Pandemic
An Imperative for Psychiatrists to Act Now
The global effect of coronavirus disease 2019
(COVID-19) is at an unprecedented large scale and
changes rapidly, with lockdowns and other confine-
ment measures at place in several countries. The un-
doubtedly widespread negative effects of the COVID-19
pandemic on mental health and mental health care do
not mean that psychiatrists cannot diminish this effect.
Here, we argue that psychiatrists can act now to help
contain the current crisis.
Both the outbreak itself and the ensuing preven-
tive measures are bound to severely affect mental health
in those with and those without a history of mental ill-
ness and in health care workers. First, social isolation and
the uncertainties around the virus may bring about de-
pressive thoughts, despair, anxiety, and loneliness. Con-
sequently, psychiatric symptoms in people without a his-
tory of mental illness may emerge and preexisting
psychiatric conditions may worsen. Second, informa-
tion about institutional prevention measures may be rela-
tively hard to appraise and comply with by patients with
cognitive impairment or acute psychiatric illness. The ef-
fect of COVID-19 on mental health and mental health care
stands in contrast to the myriad measures a psychia-
trist can take to diminish the effect of the pandemic on
patients with psychiatric illness and the general popu-
lation. Here, we argue that actions can be readily taken
by psychiatrists themselves, creating an imperative for
psychiatrists to act now. We envision 5 actions that carry
the potential to reduce the effect of the COVID-19 pan-
demic within and outside the field of psychiatry.
First, we should adopt an active stance, both in out-
patient and in inpatient settings. As in other fields of out-
patient medicine, our focus should shift from elective to
emergency consultations. Psychiatrists with currently
less workload in elective care should reach out to col-
leagues working in emergency settings. In outpatient
clinics, we should actively engage in teleconsultations,
using webcams to facilitate observation. Using telecon-
sultations, we can contact close ones of patients and en-
sure they receive proper psychoeducation and engage
over the internet with these patients. Thus, we ensure
they aren’t lost to follow-up or discontinue treatments.
In addition, we should not lose sight of our colleagues
working in emergency settings and dealing with unusu-
ally heavy workloads. Moreover, treatment adherence
may be jeopardized as patients feel reluctant to fill their
prescriptions. We should actively discuss possible new
sources of nonadherence. Moreover, we should realize
specific people and patients are susceptible to the psy-
chological effect of the pandemic and to contracting and
spreading the virus (eg, refugees and homeless). Fur-
thermore, abstinence syndromes may be more
commonly observed as access to illicit drugs becomes
cumbersome.1 Early recognition and treatment of such
syndromes are essential. Vice versa, we should be wary
of newly arising addictive behaviors, eg, addiction to
gaming in people with less workload resulting from the
recent millions of layoffs. Finally, psychiatrists working
in inpatient settings should consider preparing for psy-
chiatric patients who have tested positive for COVID-19
by creating specialized units for such patients.
Second, psychiatrists should help prevent further
spreading of COVID-19 by patients vulnerable to men-
tal illness. We should actively educate patients about the
importance and possible consequences of social isola-
tion. We should be available (online and by phone) to
loved ones and health care workers dealing with those
with COVID-19. We can help ensure institutional web-
sites have appropriate contact information for such re-
quests. For both patients and the general population, we
should emphasize the availability of information about
stressors of quarantine and ways to promote general
well-being during quarantine.2 Importantly, particular
characteristics of psychiatric disorders put people at in-
creased risk to not abide by quarantine measures. For
instance, manic episodes often entail hazardous behav-
ior, putting people at risk to contract and transmit the
virus. Those with psychotic beliefs may find it hard to dis-
tinguish between fake and real news. As specific disor-
ders come with specific risks, tailor-made measures
should thus be implemented by caregivers familiar with
patients’ individual symptom profiles and social situa-
tions. Those measures will hopefully enable patients to
openly speak about their adherence to quarantine mea-
sures and discuss ways to improve their adherence if
needed.
Third, although it is unknown how long the current
health care crisis will last, we should rethink current treat-
ments. When medicine deliveries to pharmacies are jeop-
ardized or pharmacies close due to lack of personnel, ac-
cess to medication may be challenging. Compounds with
long half-lives generally carry less severe adverse and re-
bound effects when (temporarily) discontinued. Thus,
patients taking a relatively high-frequency intramuscu-
lar depot antipsychotic could be switched to less fre-
quent formulations, eg, patients taking long-acting in-
jectable paliperidone who have been stable for 4 months
can be switched to 4 yearly injections. Additionally, we
should be wary of current or possible future interac-
tions with COVID-19 medication. A list from the Univer-
sity of Liverpool3 indicates that in terms of interac-
tions, olanzapine is one of the preferred antipsychotics;
of benzodiazepines, lorazepam/lormetazepam, oxaz-
epam, and temazepam (LLOT) are preferred; and with
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regards to antidepressants, fluoxetine, fluvoxamine, and sertraline
seem safest. Thus, medications with long half-lives and low risk of
cardiac adverse effects may be preferred should (temporary) dis-
continuations arise due to medication shortages and limited ac-
cess to pharmacies, eg, fluoxetine in new patients with anxiety or
depression.
Fourth, psychiatrists should try to counteract and analyze the
undesired effects of the current health care crisis on those with and
without a mental illness history. Recently, the World Health Orga-
nization issued recommendations for citizens to prevent anxiety and
stress in the current era.4 Similar recommendations have been given
to health care workers, eg, by the American Psychiatric Association.5
Longer-term economic effects will put people at risk of poor men-
tal health outcomes (including suicide). Preventive measures may
include psychoeducational sessions and easy (online) access to men-
tal health care in the working environment. Researchers working with
prospective registries should consider analyzing the effects of the
crisis on mental health outcomes to better predict the effects on
mental health during future outbreaks.
Finally, webinars can foster educational sessions allowing psy-
chiatry residents and medical students to continue developing their
skills. Instead of canceling educational sessions, we should rethink
them and prioritize issues and opportunities that are currently press-
ing, eg, teleconsultations, long-life medicines, suicide prevention,
COVID-19 in the context of psychiatry, and abstinence syndromes.
Such sessions can go from journal clubs to clinical case conferences
discussing clinical dilemmas in psychiatry arising from the COVID-19
pandemic. In our experience, such lively webinar sessions with resi-
dents and staff also enable experienced psychiatrists to remain up-
dated about diagnosis and treatment of COVID-19 as well as their
implications for the field of psychiatry.
In the current COVID-19 crisis of uncertain duration and effect
on society, rather than a wait-and-see approach, we recommend psy-
chiatrists make active use of the several opportunities at hand to op-
timize care for people with and without a history of mental illness
now. The above-mentioned actions may not only mitigate worsen-
ing mental health statistics (eg, incidence of psychiatric disorders
and suicide) but also result in a lower frequency of COVID-19 trans-
missions from patients with psychiatric illness to others. At the same
time, recommendations can easily become outdated, and there-
fore, psychiatrists should also feel free to speak out and advise col-
leagues on internet platforms and social media.
ARTICLE INFORMATION
Published Online: May 27, 2020.
doi:10.1001/jamapsychiatry.2020.1225
Conflict of Interest Disclosures: None reported.
Additional Contributions: Paul Naarding, MD, PhD
(Department of Old Age Psychiatry, GGNet Mental
Health, Warnsveld, the Netherlands), and Sisco van
Veen, MD (Department of Medical Humanities,
Amsterdam University Medical Center, Location
VUmc, Amsterdam, the Netherlands), provided
valuable feedback on the manuscript. Neither
received compensation for their contribution.
REFERENCES
1. Ritchie EC. What psychiatrists can do to prepare
for the coming pandemic. Accessed April 21, 2020.
https://www.medscape.com/viewarticle/926585
2. Center for the study of Traumatic Stress.
Psychological effects of quarantine during the
coronavirus outbreak: what healthcare providers




3. Liverpool Drug Interaction Group. COVID-19
drug interactions. Accessed April 21, 2020. https://
www.covid19-druginteractions.org/
4. World Health Organization. Mental health and
psychosocial considerations during the COVID-19
outbreak. Accessed April 21, 2020. https://www.
who.int/docs/default-source/coronaviruse/mental-
health-considerations.pdf?sfvrsn=6d3578af_2
5. American Psychiatric Association. COVID-19 and
mental health: caring for the public and ourselves.





1098 JAMA Psychiatry November 2020 Volume 77, Number 11 (Reprinted) jamapsychiatry.com
© 2020 American Medical Association. All rights reserved.
Downloaded From: https://jamanetwork.com/ by a Vrije Universiteit User  on 02/26/2021
